Name

TBP

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for TBP

Name

Alternate Names

Oncotepa
Oncotiotepa
Tepa
Tespa
Tespa-min
Tespamine
Thio
Thio-tepa
Thiofozil
Thiophosphamide
Thioplex
Thiotef
Tifosyl
Tio-TEF
Tiofosfamid
Tiofosyl (Sweden)
Tiofozil
Triethylene thiophosphoramide
WR-45312

Abbreviations

STEPA
TESP
TESPA
Thio-TEPA
TSP
TSPA

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

006396
6396

Primary Site

None

Histology

None

Remarks

Cell cycle nonspecific chemotherapeutic agent. FDA approved uses on intravesicular bladder carcinoma, breast adenocarcinoma, malignant intracavitary effusions, Hodgkin's lymphoma, lymphosarcoma, and ovarian adenocarcinoma. Alkylating agent.

Coding

This drug should be coded

Name

Alternate Names

Alti-Prednisone
Alto-Pred
Ancortone
Apo-Prednisone
Colisone
Cortan
Dacortin
Delta-Dome#
Deltasone
Deltra
Fernisone Buffered
Keysone
Liquid Pred
Meticorten
Novo-Prednisone
Orasone
Panasol
Paracort#
Prednicen M
SK-Prednisone
Sterapred DS
Ultracorten
Winpred

Abbreviations

PDN
PRD
PRED

Category

Hormones and hormonal mechanisms

Subcategory

Glucocorticoid

NSC Number

10023
010023

Primary Site

Prednisone is used in regimens to treat multiple sites and histologies

Histology

None

Remarks

Code Prednisone when it is part of a drug regimen.

Do not code Prednisone when it is given to treat symptoms or as a single agent. In most cases when Prednisone is given by itself and not as part of a drug regimen, it does not affect the cancer and would not be coded as treatment.

Coding

Please see remarks for additional information

Name

Alternate Names

Blenoxane
Bleo
Bleo-Cell
Bleo-S
Bleomycin for Injection
Bleomycin sulfate
Oil Bleo

Abbreviations

BLE
BLEO
BLM

Category

Chemotherapy

Subcategory

Antitumor antibiotic

NSC Number

125066

Primary Site

Squamous cell cancers

Histology

None

Remarks

Phase III melanoma Anti-tumor antibiotic; Genetronics. FDA approved uses on squamous cell cervical cancer, head & neck cancer, Hodgkin's and non-Hodgkin's lymphoma, nasopharyngeal cancer, carcinoma, and testicular cancer.

Coding

This drug should be coded
Glossary